SCAI: Benefits of paclitaxel-coated devices outweigh risks - Healio

SCAI: Benefits of paclitaxel-coated devices outweigh risks  Healio

Based on current evidence, the benefits of paclitaxel-coated devices for treatment of peripheral artery disease outweigh the risks, but doctors should discuss ...



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management